SerraGold - 60 Caps
SerraGold is a proteolytic enzyme blend that contains Serratiopeptidase, or Serrapeptase, as it is sometimes called. It represents one of the most potent enzyme formulas available in the category. SerraGold has been formulated using the potent Serratiopeptidase enzyme and Enzymedica's unique Protease Thera-blend and is intended for those seeking the highest potency Serratiopeptidase available.
Additional Information about SerraGold:
Serratiopeptidase: Serratiopeptidase (serrapeptase)is a proteolytic enzyme originally discovered in the digestive tract of the Japanese silk worm but is now derived almost exclusively from bacteria of the genus Serratia strain. Serratiopeptidase has proven to be effective in improving circulation, speeding tissue repair, alleviating joint discomfort, supporting cardiovascular health, relieving respiratory complaints and having anti-edema qualities.1-6 Serratiopeptidase has even been shown effective in transferring antibiotics to the site of infection and is now widely used in Germany as an alternative for many of these issues.7,8 It has such broad ranging effects because of its possible mechanisms of action. There are three ways Serratiopeptidase is believed to act, 1) through the elimination of inflammatory mediators, 2) through the acceleration of liquefaction of pus and sputum, and 3) through the enhancement of the action of antibiotics.9,10 Because Serratiopeptidase is an enzyme, specifically a protease, it has the ability to survive the digestive tract and cross into the blood stream remaining active.11
Protease TheraBlend. Enzymedica's Protease Thera-blend has had long running success both digestively and therapeutically. Protease given therapeutically may be involved in many different types of healing in the body including the digestion of protein pathogens, increasing circulation, eliminating waste and supporting the immune system.
Mineral Blend. The mineral blend found in SerraGold makes taking a high dose proteolytic formula easy on the stomach. It consists of calcium / magnesium ratio of 2:1 along with numerous trace minerals.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent disease.
References: 1.) Anti-inflammatory oral enzyme Dr. R.M. Bhansali, Head Dept of Orthopedics, K.E.M. Hospital Bomba. Seth Dhurmal Bajaj Orthopedic Center 2.) Nieper, HA. Basic Cardiovascular Packet. Richland Center, Wisc: Brewer Science Library 3.) Mazzonie, A. et al.. Evaluation of serrapeptase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind randomized trial verses placebo. J. int. Med. Res. 1990. 18 (5), 379-388. 4.) Matsudo, A. et at. Effect of serrapeptase (Danzen) on inflammatory edema following operation for thyropid disease. Med. Consult. New Remedy 18:171-175, 1981. 5.) A preliminary trial of serratiopeptidase in patients with carpel tunnel syndrome. J Assoc Physicians India. 1999 Sec; 47 (12): 1170-2; Comment in: J Assoc Physicians India. 2000 Nov; 48(11) : 1130.Panagariya A. Sharma AK.Dept. of Neurology, SMS Medical College and Hospital, Jaiper. 6.) Fujisaki S, Tomioka C, Uchida K. Preventative/therapeutic agent for hepatitis B and C. Patent Abstracts of Japan JP11199509 A; July 27, 1999. 7.) Serratiopeptidase and Antibiotic Transferance Okumura et al 1977 ; Ishihara 1983 8. )Aso T et al. Breast engorgement and it's treatment: Clinical effects of Danzen an anti-inflammatory enzyme preparation. The World of Obstetrics and Gynocology (Japanese). 1981:33:371-9. 9.) Mazzone A, et al. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo. J Int Med Res. 1990; 18(5):379-88. 10.) Role of Serratiopeptidase in Chronic Sinusitis Dept of E.N.T. Govt. Medical College, Srinagar 11.) Intestinal absorption of serrapeptase (TSP) in rats. Moriya N, Nakata M, Nakamura M, Takaoka M, Iwasa S Kato K, Kakinuma A. Biotechnology Research Laboratories, Takeda Chemical Industries Ltd., Osaka, Japan.
*These statements have not been evaluated by the Food and Drug Administration Board